THC administration attenuated pre-speech ITC in the 150 ms before the onset of self-generated speech, primarily at 3.9 Hz, but also at 7.8 Hz (3.9 Hz: t = 4.78, df = 15, P = 0.0002; 7.8 Hz: t = 2.63, df = 15, P = 0.02, Figure 1 ). The ITC reduction was specific to speech generation, as there was no difference in ITC between THC and placebo conditions before the onset of the visual cue used in the task at frontal or occipital electrode sites. At 11.7 Hz, THC led to a modest increase in ITC (t = 2.29, df = 15, P = 0.04), and there was a trend for increase in ITC at 15.6 Hz (t = 1.96, df = 15, P = 0.07).
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The degree of reduction in 3.9 Hz ITC 150-0 ms before onset of vocalisation was related to increasing self-rated measures of salience, simplifying to a single term-'my thoughts are more special or significant than usual' (F 1,14 = 4.69, P = 0.048). It was also related to increasing self-rated measures of ipseity disturbance, simplifying to a single term-'I believe my mind is being read' (F 1,14 = 7.871, P = 0.014). There was no relationship between ITC changes in any other frequency band with self-rated measures of cannabis effects.
These results provide the first evidence that THC disrupts ITC before the onset of self-generated vocalisation, and that the degree of disruption is related to THC-induced psychological effects. The findings show considerable overlap with previously reported data in patients with schizophrenia, 2 although the frequency changes reported here are in a lower frequency band. This may reflect the lower frequency resolution used in the schizophrenia study, where changes in theta-and alpha-range ITC would have contributed to the lowest resolvable frequency at 15.6 Hz. However, it is also possible the ITC prevocalisation changes in schizophrenia have a different frequency composition to those found under THC, pointing to a difference in efference processing dysfunction in the two conditions. Whether the effect of THC is the same or closely related to that found in schizophrenia, our findings indicate modulation of ITC by THC may be a useful biomarker for the development of novel antipsychotic drugs.
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The authors declare no conflict of interest. Methamphetamine (MA) abuse, a prevalent problem with considerable public health and criminal justice costs, 1 resembles other addictive disorders in its association with deficits in striatal dopamine receptor availability. 2, 3 This commonality is linked with the propensity to develop addictions via the Reward Deficiency Hypothesis. 4 Despite observations of low striatal dopamine receptor availability both in individuals with MA dependence 5 and those who have obesity, 3, 6 empirical measures of eating dysregulation and propensity to obesity among abstinent MAdependent individuals have not been reported. According to the Reward Deficiency Hypothesis, addicted individuals would seek out alternative rewards (for example, food) in the absence of their preferred pathological rewarding outlet (for example, MA abuse) to compensate for their deficient striatal dopamine signaling. To test the applicability of this hypothesis to MA dependence, we measured striatal dopamine D 2/3 receptor availability as well as caloric intake and weight gain in MA-dependent research participants during early abstinence from MA.
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In all, 20 non-treatment-seeking MA-dependent research participants resided on a hospital inpatient research ward as previously described, 5 with approval from the UCLA Institutional Review Board. Aside from MA and nicotine dependence, the participants were otherwise healthy, and suffered from no other comorbid conditions. The participants were allowed to eat and smoke ad libitum during the study, with abstinence from alcohol and illicit substances confirmed by daily breathalyzer and urine drug screening. Complete daily calorie counts were assessed over days 3-7 and 28-32 of the inpatient stays. Participants were weighed on admission and weekly thereafter, in the morning. Positron emission tomography (PET) scanning with [ 18 F]fallypride was performed, as previously described, 5 on days 4-8. Statistical comparisons across time points were conducted using linear mixed effects modeling. As measures of D 2/3 receptor availability in different striatal regions were highly correlated (r's X0.7), they were averaged for regional correlations of receptor availability with caloric intake. Region of interest correlations were conducted using Spearman's rank-order correlation. Striatal correlation maps ( Figure 1) were prepared using non-parametric regression as previously described. 5 Calorie counts during days 3-7 of abstinence were complete for 20 participants: 11 men (58%), 13 of whom were ethnically White (68%), average age of 35.6 ± 8.3 years (mean ± s.d.), mostly cigarette smokers (n = 18, 90%). They had been using MA for 13.2±8.6 years on average, and 18.6±8.1 days of the last 30 before admission. On average, they consumed 4277 ± 1121 kcal per day over days 3-7 of hospitalization. Calorie counts were complete in both days 3-7 and 28-33 of the hospitalization for seven participants; and participants consumed 3763 ± 1073 kcal per day over days 3-7, and 3588±621 kcal per day over days 28-32, with no group difference between time points (P = 0.71).
Eight participants had body mass index (BMI) measurements through 3 weeks of hospitalization. The average admission BMI was 26.1 ± 3.0 kg m À2 , with an increase to 28.2 ± 3.3 kg m À2 by the end of the third week (effect of time: P < 0.001), an average increase of 8.0%.
In all, 16 participants had both complete calorie counts for days 3-7 and [ 18 F]fallypride PET scans whereas eight subjects had BMI data for days 28-32 and PET scans (Figure 1 ). Days 3-7 calorie counts were not correlated with scores on the Beck Depression Inventory, Three-Factor Eating Questionnaire, smoking status, sex, ethnicity or measures of prior MA use. To control for age-related loss of striatal D 2/3 receptors, D 2/3 receptor availability was normalized to a common age, using a published estimate (4.9% loss per decade for nucleus accumbens and putamen, 5.5% loss per decade for caudate).
7 Days 3-7 calorie counts were highly correlated with striatal D 2/3 receptor availability (r = À0.54, P = 0.016, one-tailed P-value; Figure 1 ). Although third-week BMI increase did correlate with striatal D 2/3 receptor availability (r = À0.91) due to the small sample size, the results were not statistically robust (not shown).
The participants consumed more daily calories, on average, than hospitalized control subjects (for example, ref. 8) , and gained a larger proportion (8%) of their BMI over 3 weeks than a group of psychiatric inpatients taking obesogenic antipsychotic medications for 1 month (only 3% BMI gain). 9 Although the findings are compelling, some limitations of the study include the small sample size, lack of a control sample and lack of information about participants' dietary choices or smoking behavior. Nevertheless, taken together with the correlation between these measures of increased eating behavior and low striatal dopamine D 2/3 receptor availability (Figure 1 ), these observations provide support for the Reward Deficiency Hypothesis in MA dependence. 
